These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30656608)

  • 1. Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon.
    Whegang Youdom S; Chiabi A; Basco LK
    Drugs R D; 2019 Mar; 19(1):1-14. PubMed ID: 30656608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial.
    Adegbite BR; Edoa JR; Honkpehedji YJ; Zinsou FJ; Dejon-Agobe JC; Mbong-Ngwese M; Lotola-Mougueni F; Koehne E; Lalremruata A; Kreidenweiss A; Nguyen TT; Kun J; Agnandji ST; Lell B; Safiou AR; Obone Atome FA; Mombo-Ngoma G; Ramharter M; Velavan TP; Mordmüller B; Kremsner PG; Adegnika AA
    Malar J; 2019 Dec; 18(1):424. PubMed ID: 31842893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.
    Lula Ntamba Y; Muhindo Mavoko H; Kalabuanga M; Fungula B; Ntamabyaliro Nsengi PM; Tona Lutete G; Inocencio da Luz R; Van Geertruyden JP; Lutumba P
    PLoS One; 2019; 14(9):e0222379. PubMed ID: 31527899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of High In Vivo Efficacy and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine as the First- and Second-Line Treatments for Uncomplicated Plasmodium falciparum Malaria 10 Years After Their Implementation in Gabon.
    Ndong Ngomo JM; Ondzagha Megnie GJ; Moutombi Ditombi B; Koumba Lengongo JV; M'Bondoukwé NP; Offouga CL; Mawili-Mboumba DP; Lekana-Douki JB; Ringwald P; Fandeur T; Bouyou-Akotet MK
    Acta Parasitol; 2019 Dec; 64(4):898-902. PubMed ID: 31512064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
    Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
    BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial.
    Beavogui AH; Camara A; Delamou A; Diallo MS; Doumbouya A; Kourouma K; Bouedouno P; Guilavogui T; Dos Santos Souza S; Kelley J; Talundzic E; Fofana A; Plucinski MM
    Malar J; 2020 Jun; 19(1):223. PubMed ID: 32580771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
    Dentinger CM; Rakotomanga TA; Rakotondrandriana A; Rakotoarisoa A; Rason MA; Moriarty LF; Steinhardt LC; Kapesa L; Razafindrakoto J; Svigel SS; Lucchi NW; Udhayakumar V; Halsey ES; Ratsimbasoa CA
    Malar J; 2021 Nov; 20(1):432. PubMed ID: 34732201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children.
    Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO
    PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania.
    Kakolwa MA; Mahende MK; Ishengoma DS; Mandara CI; Ngasala B; Kamugisha E; Kataraihya JB; Mandike R; Mkude S; Chacky F; Njau R; Premji Z; Lemnge MM; Warsame M; Menard D; Kabanywanyi AM
    Malar J; 2018 Oct; 17(1):369. PubMed ID: 30333022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine in Niger].
    Ibrahima I; Laminou IM; Adehossi E; Maman D; Boureima S; Harouna HK; Hamidou HH; Mahamadou A; Yacouba I; Hadiza J; Tidjani IA
    Bull Soc Pathol Exot; 2020; 113(1):17-23. PubMed ID: 32881447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015-2016.
    Diarra Y; Koné O; Sangaré L; Doumbia L; Haidara DBB; Diallo M; Maiga A; Sango HA; Sidibé H; Mihigo J; Nace D; Ljolje D; Talundzic E; Udhayakumar V; Eckert E; Woodfill CJ; Moriarty LF; Lim P; Krogstad DJ; Halsey ES; Lucchi NW; Koita OA
    Malar J; 2021 May; 20(1):235. PubMed ID: 34034754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance.
    Moriarty LF; Nkoli PM; Likwela JL; Mulopo PM; Sompwe EM; Rika JM; Mavoko HM; Svigel SS; Jones S; Ntamabyaliro NY; Kaputu AK; Lucchi N; Subramaniam G; Niang M; Sadou A; Ngoyi DM; Muyembe Tamfum JJ; Schmedes SE; Plucinski MM; Chowell-Puente G; Halsey ES; Kahunu GM
    Am J Trop Med Hyg; 2021 Sep; 105(4):1067-1075. PubMed ID: 34491220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine and polymorphism in Plasmodium falciparum kelch13-propeller gene in Equatorial Guinea.
    Riloha Rivas M; Warsame M; Mbá Andeme R; Nsue Esidang S; Ncogo PR; Phiri WP; Oki Eburi C; Edú Maye CE; Menard D; Legrand E; Berzosa P; Garcia L; Lao Seoane AK; Ntabangana SC; Ringwald P
    Malar J; 2021 Jun; 20(1):275. PubMed ID: 34158055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.
    Sondo P; Derra K; Diallo-Nakanabo S; Tarnagda Z; Zampa O; Kazienga A; Valea I; Sorgho H; Owusu-Dabo E; Ouedraogo JB; Guiguemde TR; Tinto H
    Malar J; 2015 Aug; 14():325. PubMed ID: 26289949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.
    Sylla K; Abiola A; Tine RC; Faye B; Sow D; Ndiaye JL; Ndiaye M; Lo AC; Folly K; Ndiaye LA; Gaye O
    BMC Infect Dis; 2013 Dec; 13():598. PubMed ID: 24354627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.
    Diallo MA; Yade MS; Ndiaye YD; Diallo I; Diongue K; Sy SA; Sy M; Seck MC; Ndiaye M; Dieye B; Gomis JF; Sow D; Dème AB; Badiane AS; Ndiaye D
    Sci Rep; 2020 Jun; 10(1):8907. PubMed ID: 32483161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.